Clinical Trials Browser

Breast Neoplasms

DMMR Colorectal Cancer

Pancreatic Neoplasms

Advanced Solid Tumor

Stomach Neoplasms

Breast Diseases, Breast Neoplasms

Breast Neoplasms, Triple Negative Breast Neoplasms

Esophageal Squamous Cell Carcinoma

HER2-positive Metastatic Breast Cancer

Locally Advanced Rectal Cancer

Breast Neoplasms

Esophageal Squamous Cell Carcinoma

Pancreatic Neoplasms

Stomach Neoplasms

Triple Negative Breast Neoplasms

Colorectal Neoplasms

Breast Neoplasms

Rectal Neoplasms

Digestive System Neoplasms

Esophageal Squamous Cell Carcinoma

Colorectal Neoplasms

Rectal Neoplasms

Colonic Neoplasms, Colorectal Neoplasms

Colonic Neoplasms, Colorectal Neoplasms

HER2 Positive Metastatic Breast Cancer

Breast Neoplasms

Breast Cancer Metastatic

Colorectal Cancer Metastatic

Hypopharyngeal Neoplasms

Locally Advanced Unresectable Gastric Adenocarcinoma

Colorectal Neoplasms

Colorectal Neoplasms

Stomach Neoplasms

Breast Neoplasms

Adenocarcinoma, Neoplasms

Squamous Cell Carcinoma of Head and Neck

Advanced Breast Cancer

Anal Canal Carcinoma, Anus Neoplasms

Nasopharyngeal Carcinoma

Rectal Neoplasms

Colorectal Neoplasms

Rectal Neoplasms

Breast Neoplasms

Brain Neoplasms, Breast Neoplasms, Meningeal Neoplasms, Meningeal Carcinomatosis

Rectal Neoplasms

Waldenstrom Macroglobulinemia, Neoplasms

Colorectal Neoplasms

Breast Neoplasms

Breast Neoplasms

Clinical Trials

Disitamab Vedotin in Combination with Metronomic Chemotherapy in Advanced HER2-expressing Breast Cancer.

PD1 Antibody Toripalimab and Chemoradiotherapy for dMMR/MSI-H Locally Advanced Colorectal Cancer

NaliCap

Tolerability and Bioavailability of Utidelone Capsule in Patients With Advanced Solid Tumors

Study of HLX22 in Combanition With Trastuzumab and Chemotherapy Versus Placebo in Combination With Trastuzumab and Chemotherapy for Treatment of Locally Advanced or Metastatic Gastric Cancer

A Study of RC48-ADC Administered Intravenously to Patients With HER2-Positive Metastatic Breast Cancer With or Without Liver Metastases

BreastImmune03

Toripalimab Plus Neoadjuvant Chemotherapy Combined With Chemoradiotherapy for Locally Advanced Unresectable Esophageal Squamous Cell Carcinoma

A Study of Pyrotinib Plus Capecitabine Combined With SRT in HER2+ MBC With Brain Metastases

Combination of AK104 and Neoadjuvant Chemoradiotherapy in pMMR/MSS Locally Advanced Rectal Cancer

A Study of RC48-ADC for the Treatment of Locally Advanced or Metastatic Breast Cancer With Low Expression of HER2

Escape

Phase II Study of Concurrent Radiotherapy With Envafolimab and Capecitabine in LAPC

NIVOFGFR2

FUTURE-SUPER

DETECT

Mitoxantrone Hydrochloride Liposome Combined With Capecitabine in Patients With HER-2 Negative Advanced Breast Cancer

LARCT-US

ALTER-G-001

EC-CRT-003

REVOLUTION

RAIC

IDEA

Post-surgical Liquid Biopsy-guided Treatment of Stage III and High-risk Stage II Colon Cancer Patients: the PEGASUS Trial

A Study of Pyrotinib Plus Capecitabine in Patients With Brain Metastases From HER2-positive Metastatic Breast Cancer

A Study of QLS31905 Combination Chemotherapy as First-Line Treatment in Patients With Advanced Solid Tumors

Efficacy and Safety of Inetetamab Plus Pyrotiniband and Capecitabine in HER2-positive Metastatic Breast Cancer Patients With or Without Brain Metastasis

A Study to Evaluate the Efficacy and Safety of Margetuximab Plus Chemotherapy in the Treatment of Chinese Patients With HER2+ MBC

POCHI

Induction Chemotherapy Combined With Immunotherapy for Locally Advanced Hypopharyngeal Carcinoma

Cadonilimab Combined With CapeOX Regimen in Perioperative Treatment of Resectable Locally Advanced Gastric Cancer

C-CLASSIC

Study of Chemotherapy Combination With Autologous Cell Immunotherapy in the Recurrent and Metastatic Colorectal Cancer

Efficacy of Perioperative Chemotherapy Plus PD-1 Antibody in the Locally Advanced Gastric Cancer

A Study of SHR-A1811 Combined With Capecitabine in Treatment of Unresectable or Metastatic Breast Cancer With Low HER2 Expression.

The Safety and Efficacy of Q-1802 Combined With XELOX in Gastrointestinal Tumors

Calizumab Combined With Bevacizumab and Capecitabine in the Treatment of Head and Neck Squamous Cell Carcinoma

VEX

InterAACT

EP-STAR

PANDORA

QL1706 Monotherapy or in Combination With Bevacizumab and XELOX as First-line Treatment of Unresectable Advanced or Metastatic CRC

CONVERT: Neoadjuvant Chemotherapy Alone Versus Preoperative Chemoradiation for Locally Advanced Rectal Cancer Patients

Second Line ERIbulin Followed by CApecitabine or the Reverse Sequence in HER2-negative Metastatic Breast Cancer Patients

ANGLeD

XELOX Combined With Cadonilimab Versus XELOX as Neoadjuvant Treatment for Locally Advanced, pMMR Rectal Cancer

PRECISE CURATE.AI Pilot Clinical Trial

V-shoRT-R3

Letrozole Plus Metronomic Capecitabine as First-line Treatment for Patients With Recurrent or Metastatic Breast Cancer

Oral Vinorelbine and Capecitabine in Advanced HER2-negative Breast Cancer